Subscribe To Our Free Newsletter |
Reduce Glenmark Pharmaceuticals, target price Rs 660: ICICI Securities
Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2022.